Search research articles
Contact Us
Filters
Showing results (91-100 of 126) with videos related to
Page
of 13
Sort By:
Gut
|
April 1, 1995
Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group
C M Bate, S N Booth, J P Crowe, et al.
The Journal of Comparative Neurology
|
November 20, 1998
Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys
M E Emborg, S Y Ma, E J Mufson, et al.
Journal of Medicinal Chemistry
|
September 3, 1993
Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variation
C M Rao, P E Scarborough, J Kay, et al.
Public Health
|
June 27, 2003
The Scottish mental survey 1932 linked to the Midspan studies: a prospective investigation of childhood intelligence and future health
C L Hart, I J Deary, M D Taylor, et al.
Oncogene
|
March 18, 2014
The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants
M C Buss, M Remke, J Lee, et al.
Journal of Medicinal Chemistry
|
July 1, 1991
Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationships
I Sircar, E K Gregor, K R Anderson, et al.
Journal of Molecular and Cellular Cardiology
|
May 2, 2013
Altered regional cardiac wall mechanics are associated with differential cardiomyocyte calcium handling due to nebulette mutations in preclinical inherited dilated cardiomyopathy
K Maiellaro-Rafferty, J P Wansapura, U Mendsaikhan, et al.
Neurology
|
October 16, 1999
FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa
W D Brown, M D Taylor, A D Roberts, et al.
Alimentary Pharmacology & Therapeutics
|
January 9, 1999
Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group
J R Green, J A Gibson, G D Kerr, et al.
Gastroenterology
|
January 15, 1998
Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group
J R Green, A J Lobo, C D Holdsworth, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 126) with videos related to
Sort By:
Page
of 13
Gut
|
April 1, 1995
Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group
C M Bate, S N Booth, J P Crowe, et al.
The Journal of Comparative Neurology
|
November 20, 1998
Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys
M E Emborg, S Y Ma, E J Mufson, et al.
Journal of Medicinal Chemistry
|
September 3, 1993
Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variation
C M Rao, P E Scarborough, J Kay, et al.
Public Health
|
June 27, 2003
The Scottish mental survey 1932 linked to the Midspan studies: a prospective investigation of childhood intelligence and future health
C L Hart, I J Deary, M D Taylor, et al.
Oncogene
|
March 18, 2014
The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants
M C Buss, M Remke, J Lee, et al.
Journal of Medicinal Chemistry
|
July 1, 1991
Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationships
I Sircar, E K Gregor, K R Anderson, et al.
Journal of Molecular and Cellular Cardiology
|
May 2, 2013
Altered regional cardiac wall mechanics are associated with differential cardiomyocyte calcium handling due to nebulette mutations in preclinical inherited dilated cardiomyopathy
K Maiellaro-Rafferty, J P Wansapura, U Mendsaikhan, et al.
Neurology
|
October 16, 1999
FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa
W D Brown, M D Taylor, A D Roberts, et al.
Alimentary Pharmacology & Therapeutics
|
January 9, 1999
Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group
J R Green, J A Gibson, G D Kerr, et al.
Gastroenterology
|
January 15, 1998
Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group
J R Green, A J Lobo, C D Holdsworth, et al.
Page
of 13